Protective immunity induced by low-virulence Candida albicans: Cytokine production in the development of the anti-infectious state
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 124 (2) , 334-344
- https://doi.org/10.1016/0008-8749(89)90135-4
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1European Journal of Immunology, 1988
- Immunomodulation by a low-virulence, agerminative variant ofCandida albicans. Further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protectionMedical Mycology, 1988
- LymphokinesNew England Journal of Medicine, 1987
- Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractionsJournal of Medical Microbiology, 1986
- Role of prostaglandin E and interferon in secretion of colony-stimulating factor by murine macrophages after in vitro treatment with biological response modifiersInternational Journal of Immunopharmacology, 1984
- Phagocytic killing ofCandida albicansby different murine effector cellsMedical Mycology, 1983
- A radiolabel release microassay for phagocytic killing of Candida albicansJournal of Immunological Methods, 1982
- Direct Comparison of Three Isotopic Release Microtoxicity Assays as Measures of Cell-Mediated Immunity to Gross Virus-Induced Lymphomas in RatsJNCI Journal of the National Cancer Institute, 1977
- Progressive Loss of H-2 Antigens With Concomitant Increase of Cell-Surface Antigen(s) Determined by Moloney Leukemia Virus in Cultured Murine Lymphomas23JNCI Journal of the National Cancer Institute, 1973
- Studies in Antibody Response of Mice to Tumour InoculationBritish Journal of Cancer, 1950